LeMaitre Vascular, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 87.00 M

LeMaitre Vascular, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 87.00 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 18.65% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • LeMaitre Vascular, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 73.32 M, a 12.12% change year over year.
  • LeMaitre Vascular, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 65.39 M, a 18.36% change year over year.
  • LeMaitre Vascular, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 55.25 M, a 19.91% change year over year.
  • LeMaitre Vascular, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 46.07 M, a -7.37% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue